An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Active, not recruiting · NCT06169397 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Active, not recruiting | Phase 2 | 2026-08-21 | NCT06169397 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xentria, Inc. | 4 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| King's College Hospital NHS Foundation Trust | London | United Kingdom | 2 |
| NHS Tayside | Perth | United Kingdom | 2 |
| Norfolk and Norwich University Hospitals NHS Foundation Trust | Norwich | United Kingdom | 1 |
| University Hospitals Coventry and Warwickshire NHS Trust | Coventry | United Kingdom | 2 |